Fingerprint
Dive into the research topics of 'A phase ib dose-escalation study of the safety, tolerability, and pharmacokinetics of cobimetinib and duligotuzumab in patients with previously treated locally advanced ormetastatic cancers with mutant KRAS'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically